Suppr超能文献

三例疑似舒更葡糖钠所致过敏性休克病例。

Three suspected cases of sugammadex-induced anaphylactic shock.

作者信息

Takazawa Tomonori, Tomita Yukinari, Yoshida Nagahide, Tomioka Akihiro, Horiuchi Tatsuo, Nagata Chie, Orihara Masaki, Yamada Makiko Hardy, Saito Shigeru

机构信息

Department of Anesthesiology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, 371-8511 Japan.

Department of Anesthesiology, Isesaki Municipal Hospital, 12-1 Tsunatorihoncho, Isesaki, 372-0817 Japan.

出版信息

BMC Anesthesiol. 2014 Oct 17;14:92. doi: 10.1186/1471-2253-14-92. eCollection 2014.

Abstract

BACKGROUND

Sugammadex has a unique mechanism of action and is widely used because of its safety and efficacy. A few recent reports have described allergic reactions to clinical doses of sugammadex. We hereby describe another series of cases of possible anaphylaxis to sugammadex.

CASE PRESENTATION

We present three suspected cases of sugammadex-induced anaphylactic shock, including a 13-year-old boy who underwent laparoscopic appendectomy, a 75-year-old woman who underwent left knee arthroplasty, and a 34-year-old man who underwent left pansinectomy for sinobronchitis. All three patients received general anesthesia with rocuronium and their tracheas were intubated. Shortly after injection of sugammadex for reversal of rocuronium, all of them experienced a decrease in blood pressure along with mucocutaneous erythema. In the most severe case, reintubation after extubation was required due to difficulty in manual ventilation. All patients recovered with anti-allergic therapy. On later investigation, all three patients had a positive skin reaction to sugammadex.

CONCLUSION

Our results suggest that physicians using sugammadex should be aware of the possibility of sugammadex-induced anaphylaxis.

摘要

背景

舒更葡糖钠具有独特的作用机制,因其安全性和有效性而被广泛使用。最近有一些报告描述了对临床剂量舒更葡糖钠的过敏反应。我们在此描述另一系列可能对舒更葡糖钠发生过敏反应的病例。

病例报告

我们报告了3例疑似舒更葡糖钠引起的过敏性休克病例,包括1例接受腹腔镜阑尾切除术的13岁男孩、1例接受左膝关节置换术的75岁女性和1例因鼻窦支气管炎接受左全肺切除术的34岁男性。所有3例患者均接受了罗库溴铵全身麻醉并进行气管插管。在注射舒更葡糖钠用于逆转罗库溴铵作用后不久,他们均出现血压下降并伴有皮肤黏膜红斑。在最严重的病例中,由于手动通气困难,拔管后需要重新插管。所有患者经抗过敏治疗后康复。在后续调查中,所有3例患者对舒更葡糖钠的皮肤反应均呈阳性。

结论

我们的结果表明,使用舒更葡糖钠的医生应意识到舒更葡糖钠引起过敏反应的可能性。

相似文献

1
Three suspected cases of sugammadex-induced anaphylactic shock.三例疑似舒更葡糖钠所致过敏性休克病例。
BMC Anesthesiol. 2014 Oct 17;14:92. doi: 10.1186/1471-2253-14-92. eCollection 2014.
6
Allergy to low dose sugammadex.对低剂量 sugammadex 的过敏反应。
Anaesthesia. 2011 Mar;66(3):217-9. doi: 10.1111/j.1365-2044.2010.06611.x.
7
Sugammadex and rocuronium-induced anaphylaxis.舒更葡糖钠与罗库溴铵诱发的过敏反应。
J Anesth. 2016 Apr;30(2):290-7. doi: 10.1007/s00540-015-2105-x. Epub 2015 Dec 8.

引用本文的文献

2
Sugammadex in Emergency Situations.紧急情况下的舒更葡糖钠
J Pers Med. 2023 Jan 15;13(1):159. doi: 10.3390/jpm13010159.
3
Sugammadex-induced anaphylactic reaction: A systematic review.舒更葡糖钠引起的过敏反应:一项系统评价。
J Anaesthesiol Clin Pharmacol. 2022 Jul-Sep;38(3):360-370. doi: 10.4103/joacp.JOACP_573_20. Epub 2022 Feb 8.
5
Dl-3-n-butylphthalide induced anaphylactic shock: a case report.dl-3-正丁基苯酞致过敏性休克:1 例报告。
Eur J Hosp Pharm. 2023 Sep;30(5):e23. doi: 10.1136/ejhpharm-2021-003124. Epub 2022 Jan 27.
6
Sugammadex and anaphylaxis: An analysis of 33 published cases.舒更葡糖钠与过敏反应:33例已发表病例分析
J Anaesthesiol Clin Pharmacol. 2021 Apr-Jun;37(2):153-159. doi: 10.4103/joacp.JOACP_383_19. Epub 2021 Jul 15.
10
Sugammadex-Induced Hypersensitivity Reaction in a Pediatric Patient.舒更葡糖钠致小儿患者过敏反应
Turk J Anaesthesiol Reanim. 2018 Feb;46(1):66-68. doi: 10.5152/TJAR.2018.04696. Epub 2018 Feb 1.

本文引用的文献

2
Sugammadex hypersensitivity-a case of anaphylaxis.舒更葡糖钠超敏反应——1例过敏反应病例
Anaesth Intensive Care. 2014 Jan;42(1):89-92. doi: 10.1177/0310057X1404200115.
8
Allergy to low dose sugammadex.对低剂量 sugammadex 的过敏反应。
Anaesthesia. 2011 Mar;66(3):217-9. doi: 10.1111/j.1365-2044.2010.06611.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验